Search research articles
Contact Us
Filters
Showing results (71-80 of 92) with videos related to
Page
of 10
Sort By:
Journal of Immunology Research
|
June 29, 2018
NMO-IgG and AQP4 Peptide Can Induce Aggravation of EAMG and Immune-Mediated Muscle Weakness
Tehila Mizrachi, Livnat Brill, Malcolm Rabie, et al.
Multiple Sclerosis and Related Disorders
|
January 15, 2026
Chronic stress amplifies multidimensional disease activity in multiple sclerosis patients: A year-long within-person analysis
Omri Zveik-Lavi, Dvir Green, Ariel Rechtman, et al.
Journal of Neuroimmunology
|
April 7, 2016
Increased occurrence of anti-AQP4 seropositivity and unique HLA Class II associations with neuromyelitis optica (NMO), among Muslim Arabs in Israel
Livnat Brill, Micha Mandel, Dimitrios Karussis, et al.
Multiple Sclerosis and Related Disorders
|
September 9, 2022
Clinical outcomes of COVID-19 in patients with multiple sclerosis treated with ocrelizumab in the pre- and post-SARS-CoV-2 vaccination periods: Insights from Israel
Janick Weberpals, Spyros Roumpanis, Yael Barer, et al.
Journal of Neurology
|
July 12, 2023
Practical recommendations on treatment of multiple sclerosis with Cladribine: an Israeli Experts Group Viewpoint
Panayiota Petrou, Anat Achiron, Esther Ganelin Cohen, et al.
Pharmacological Research
|
August 12, 2019
MicroRNA signature associated with treatment response in myasthenia gravis: A further step towards precision medicine
Paola Cavalcante, Tehila Mizrachi, Claudia Barzago, et al.
Muscle & Nerve
|
December 12, 2013
Rare combination of myasthenia and motor neuronopathy, responsive to Msc-Ntf stem cell therapy
Panayiota Petrou, Avizohar Argov, Vanda A Lennon, et al.
JAMA Neurology
|
January 12, 2016
Safety and Clinical Effects of Mesenchymal Stem Cells Secreting Neurotrophic Factor Transplantation in Patients With Amyotrophic Lateral Sclerosis: Results of Phase 1/2 and 2a Clinical Trials
Panayiota Petrou, Yael Gothelf, Zohar Argov, et al.
Frontiers in Immunology
|
October 15, 2024
Cognitive impairments in autoimmune encephalitis: the role of autoimmune antibodies and oligoclonal bands
Ayal Rozenberg, Shahar Shelly, Adi Vaknin-Dembinsky, et al.
Brain and Behavior
|
June 28, 2024
The effect of COVID-19 vaccination on multiple sclerosis activity as reflected by MRI
Esther Ganelin-Cohen, Chen Buxbaum, Noam Bosak, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 92) with videos related to
Sort By:
Page
of 10
Journal of Immunology Research
|
June 29, 2018
NMO-IgG and AQP4 Peptide Can Induce Aggravation of EAMG and Immune-Mediated Muscle Weakness
Tehila Mizrachi, Livnat Brill, Malcolm Rabie, et al.
Multiple Sclerosis and Related Disorders
|
January 15, 2026
Chronic stress amplifies multidimensional disease activity in multiple sclerosis patients: A year-long within-person analysis
Omri Zveik-Lavi, Dvir Green, Ariel Rechtman, et al.
Journal of Neuroimmunology
|
April 7, 2016
Increased occurrence of anti-AQP4 seropositivity and unique HLA Class II associations with neuromyelitis optica (NMO), among Muslim Arabs in Israel
Livnat Brill, Micha Mandel, Dimitrios Karussis, et al.
Multiple Sclerosis and Related Disorders
|
September 9, 2022
Clinical outcomes of COVID-19 in patients with multiple sclerosis treated with ocrelizumab in the pre- and post-SARS-CoV-2 vaccination periods: Insights from Israel
Janick Weberpals, Spyros Roumpanis, Yael Barer, et al.
Journal of Neurology
|
July 12, 2023
Practical recommendations on treatment of multiple sclerosis with Cladribine: an Israeli Experts Group Viewpoint
Panayiota Petrou, Anat Achiron, Esther Ganelin Cohen, et al.
Pharmacological Research
|
August 12, 2019
MicroRNA signature associated with treatment response in myasthenia gravis: A further step towards precision medicine
Paola Cavalcante, Tehila Mizrachi, Claudia Barzago, et al.
Muscle & Nerve
|
December 12, 2013
Rare combination of myasthenia and motor neuronopathy, responsive to Msc-Ntf stem cell therapy
Panayiota Petrou, Avizohar Argov, Vanda A Lennon, et al.
JAMA Neurology
|
January 12, 2016
Safety and Clinical Effects of Mesenchymal Stem Cells Secreting Neurotrophic Factor Transplantation in Patients With Amyotrophic Lateral Sclerosis: Results of Phase 1/2 and 2a Clinical Trials
Panayiota Petrou, Yael Gothelf, Zohar Argov, et al.
Frontiers in Immunology
|
October 15, 2024
Cognitive impairments in autoimmune encephalitis: the role of autoimmune antibodies and oligoclonal bands
Ayal Rozenberg, Shahar Shelly, Adi Vaknin-Dembinsky, et al.
Brain and Behavior
|
June 28, 2024
The effect of COVID-19 vaccination on multiple sclerosis activity as reflected by MRI
Esther Ganelin-Cohen, Chen Buxbaum, Noam Bosak, et al.
Page
of 10